dbphxnd.info

No general screening test is more efficient, effective and affordable than a comprehensive blood chemistry panel. It allows the healthcare provider to establish a baseline of biomarkers to track the patient’s health and nutritional needs. Getting a blood test is essential to understanding your current health and your nutritional needs.What is Blood Nutrition? Blood NutritionTM, is an innovative, science-guided look at nutritional strengths and weaknesses through an individual’s blood test. This new scientific approach can offer a clear plan for your optimum health. As a result, a new generation of healthcare professionals is emerging with the tools and keys that can reveal the more subtle imbalances and assist in correcting them. Blood NutritionTM is a comprehensive approach to health. To address the true cause of symptoms, one should look for their origin from a science-generated perspective by considering:Physiological distress or disease conditionsNutritional distress or imbalancesMental/emotional distressAny of these factors may be the source or a contributing factor for the symptoms of imbalance. The cornerstone of an effective health strategy is a nutritional and lifestyle plan that is based on your biochemistry. Success here is dependent on the establishment of an accurate nutritional profile guided by scientific approaches such as a comprehensive blood test. Blood Nutrition and Science This advanced scientific approach identifies nutritionally significant information through the careful analysis of the various blood values. Certain indicators can reveal electrolyte, mineral and other nutritional imbalances. Once addressed, one can optimize the metabolic processes and help maintain the healthy performance of the body. A balanced nutritional state is essential for achieving and maintaining health. Nutritional analysis of your Blood Test may indicate the need for:Key nutrients such as vitamin A, B6, B12, DFluid and electrolyte balanceMinerals such as magnesium, calcium and ironTissue hydrationAntioxidantsEnzymesNutritional support of key organsNutritional support of metabolic pathwaysThe need for lifestyle changesNutritional Imbalances If you have nutritional imbalances, you may be experiencing the following:Mental/emotional symptoms including mood swings and anxietyStructural/musculoskeletal symptoms such as pain or stiffnessDigestive issues such as bloating, indigestion and elimination problemsOptical symptoms such as difficulty in night vision or blurry visionSymptoms such as weight gain, fatigue, insomnia, food cravingsCardiovascular health issuesDry skin, brittle nails, hair dryness or lossOthersAre you suffering from the effects of nutritional deficiencies or imbalances? Nutrients such as amino acids, enzymes, fatty acids, vitamins, minerals and electrolytes are the building blocks of the body. They provide energy, support metabolism and are needed for many biochemical reactions to sustain health. Key nutrients may become deficient for various reasons. These may include:Disease processes, which may block metabolismPoor dietary habitsPhysical, mental and emotional stressOne of the most scientific ways to identify nutritional imbalances is to have your blood test evaluated by a nutritionally trained doctor or healthcare practitioner who is experienced in Blood NutritionTM assessment. A comprehensive blood test is affordable and results are normally received within a few days. When key nutrients become deficient, many metabolic processes are affected.The body may initially try to compensate for such imbalances. However, if they are prolonged, they may contribute to hormonal issues, metabolic disorders, increase in toxic load, oxidative stress, organ weaknesses and many other health issues. Many symptoms such as tiredness, fatigue and irritability may be effectively addressed with proper nutritional considerations.A blood test is one of the most efficient tests you can get to determine the quality of your overall health. Once you have received your test results, working with a specialist who is experienced in Blood NutritionTM will enable you to achieve the optimum health that is essential to a long life full of vitality.

Find Nutrition Graduate Programs in the United States and Canada. If you’d like to achieve a Masters or Ph.D. in nutrition, you should first review admission requirements to nutrition graduate programs. Typically, prospective students must take an aptitude test prior to enrollment. Additionally, applicants to nutrition graduate programs must have earned a minimum undergraduate degree with an above average GPA.Common studies involved in nutrition graduate programs are research in genetic and metabolic foundations (in animal and human diets), nutritional biochemistry, pathology in relation to nutrition, nutritional epidemiology, and other related subject matter.Nutrition graduate programs that result in a Master’s (MS) degree entail in-depth coursework in biology, biochemistry, chemistry, advanced nutrition, physiology, and advanced human nutrition. In addition, students will almost always have to complete a thesis, as well as residency. Generally, nutrition graduate programs like this require a minimum of two years to complete.Doctorate (Ph.D.) nutrition graduate programs include higher studies, doctoral dissertation research, and advanced nutrition sciences and research, among other associated courses. Ph.D. program lengths vary, but usually take between three and four years to finish successfully.Students may also opt to participate in nutrition graduate programs with an emphasis on food science. These studies generally focus on food chemistry, biochemistry and microbiology; food processing, and supplementary research, thesis and residency. These nutrition graduate programs generally require the same amount of time and prerequisites as typical M.S. and Ph.D. courses.Candidates who have successfully completed nutrition graduate programs in North America have potential to earn well over $60,000 annually in a faster-than-average growing career field. In addition to the positive financial outlook, professional nutritionists and dieticians gain overall satisfaction in helping individuals to make effective dietary choices in the prevention of disease, improved health and overall wellbeing.If you (or someone you know) are interested in finding nutrition graduate programs, let professional training within fast-growing industries like massage therapy, cosmetology, acupuncture, oriental medicine, Reiki, and others get you started! Explore career school programs near you.Employment source: Bls.gov (US Bureau of Labor Statistics)Nutrition Graduate Programs in North America© Copyright 2007The CollegeBound NetworkAll Rights ReservedNOTICE: Article(s) may be republished free of charge to relevant websites, as long as Copyright and Author Resource Box are included; and ALL Hyperlinks REMAIN intact and active.

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.